AMPK couples p73 with p53 in cell fate decision

被引:36
|
作者
Adamovich, Y. [1 ]
Adler, J. [1 ]
Meltser, V. [1 ]
Reuven, N. [1 ]
Shaul, Y. [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
来源
CELL DEATH AND DIFFERENTIATION | 2014年 / 21卷 / 09期
基金
以色列科学基金会;
关键词
ACTIVATED PROTEIN-KINASE; ABL TYROSINE KINASE; DNA-DAMAGE; C-ABL; APOPTOTIC RESPONSE; REGULATES P73; P73-MEDIATED APOPTOSIS; METABOLIC CHECKPOINT; INDUCE APOPTOSIS; PHOSPHORYLATION;
D O I
10.1038/cdd.2014.60
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 family of proteins has an important role in determining cell fate in response to different types of stress, such as DNA damage, hypoxia, or oncogenic stress. In recent years, p53 has also been shown to respond to metabolic stress, and to be induced by the AMP-activated protein kinase (AMPK), a central cellular energy sensor. A bioinformatic analysis revealed three putative AMPK phopshorylation sites in p73, a p53 tumor suppressor paralog. In vitro and in vivo assays confirmed that AMPK phosphorylates p73 on a novel residue, S426. Following specific pharmacologic stimulation of AMPK in cells, p73 protein half-life was prolonged leading to p73 accumulation in the nucleus. We show that p73 escaped the E3 ligase Itch resulting in reduced p73 ubiquitination and proteasomal degradation. Furthermore, chronic activation of AMPK led to apoptosis that was p73 dependent, but only in p53-expressing cells. Surprisingly, we found that p73 was required for p53 stabilization and accumulation under AMPK activation, but was dispensable under DNA damage. Our findings couple p73 with p53 in determining cell fate under AMPK-induced metabolic stress.
引用
收藏
页码:1451 / 1459
页数:9
相关论文
共 50 条
  • [21] p73:p53的类似物
    邵丽娜
    来茂德
    国外医学遗传学分册., 2000, (02) : 73 - 76
  • [22] Family feud in chemosensitvity - p73 and mutant p53
    Irwin, MS
    CELL CYCLE, 2004, 3 (03) : 319 - 323
  • [23] Interrelations between p73 and p53:: a model, neuroblastoma
    Douc-Rasy, S
    Goldschneider, D
    Million, K
    Bénard, J
    M S-MEDECINE SCIENCES, 2004, 20 (03): : 317 - 324
  • [24] Two faces of p73, a member of p53 family
    Slade, N
    PERIODICUM BIOLOGORUM, 2004, 106 (03) : 223 - 231
  • [25] If p53 can't do it, ask p73
    Lain, Sonia
    CELL CYCLE, 2008, 7 (21) : 3290 - 3291
  • [26] Involvement of the p53 and p73 transcription factors in neuroAIDS
    Mukerjee, Ruma
    Deshmane, Satish L.
    Fan, Shongshan
    Del Valle, Luis
    White, Martyn K.
    Khalili, Kamel
    Amini, Shohreh
    Sawaya, Bassel E.
    CELL CYCLE, 2008, 7 (17) : 2682 - 2690
  • [27] Roles for p53 and p73 during oligodendrocyte development
    Billon, N
    Terrinoni, A
    Jolicoeur, C
    McCarthy, A
    Richardson, WD
    Melino, G
    Raff, M
    DEVELOPMENT, 2004, 131 (06): : 1211 - 1220
  • [28] p73 and p53 pathway in human breast cancers
    Bozzetti, Cecilia
    Nizzoli, Rita
    Musolino, Antonino
    Martella, Eugenia M.
    Crafa, Pellegrino
    Lagrasta, Costanza A.
    Camisa, Roberta
    Bonati, Antonio
    Lunghi, Paolo
    Ardizzoni, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1451 - 1453
  • [29] Prodigiosin rescues mutant p53 signaling and antitumor effects via p73 upregulation and disruption of mutant p53:p73 interaction.
    Hong, Bo
    Van den Heuvel, Antonius
    Kopelovich, Levy
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2013, 73 (08)
  • [30] Tumor suppressor p53 and its homologue p73α affect cell migration
    Sablina, AA
    Chumakov, PM
    Kopnin, BP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) : 27362 - 27371